| 1 |
Development of a4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis |
|
| | Shirin Kouhpayeh,Zahra Hejazi,Maryam Boshtam,Mina Mirian,Ilnaz Rahimmanesh,Leila Darzi,Abbas Rezaei,Laleh Shariati,Hossein Khanahmad | | | Journal of Cellular Biochemistry. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Selection and Characterization of Single-Stranded DNA Aptamers Binding Human B-Cell Surface Protein CD20 by Cell-SELEX |
|
| | Mansoureh Haghighi,Hossein Khanahmad,Abbasali Palizban | | | Molecules. 2018; 23(4): 715 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Molecular Application of Aptamers in the Diagnosis and Treatment of Cancer and Communicable Diseases |
|
| | Philisiwe Molefe,Priscilla Masamba,Babatunji Oyinloye,Londiwe Mbatha,Mervin Meyer,Abidemi Kappo | | | Pharmaceuticals. 2018; 11(4): 93 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics |
|
| | Haibin Wu,Meng Wang,Bo Dai,Yanmin Zhang,Ying Yang,Qiao Li,Mingyue Duan,Xi Zhang,Xiaomei Wang,Anmao Li,Liyu Zhang | | | Drug Delivery. 2017; 24(1): 1216 | | | [Pubmed] [Google Scholar] [DOI] | |
|
